Table 1. Clinical features and serology of APS patients.
| Patients (n = 44) | |
|---|---|
| Median age (SD) | 42 yr (10.6) |
| Sex (F:M) | 35:9 |
| Ethnicity (%) | Caucasian (97.7) |
| Diagnosis (PAPS:SAPS) | 38:6 |
| VT+/PM+ (%) | 9 (20.5) |
| PM+ (%) | 14 (31.8) |
| VT+ (%) | 21 (47.7) |
| IgG anti-DI positive | 56.8% |
| IgM anti-DI positive | 38.6% |
| IgA anti-DI positive | 47.7% |
| IgG anti-β2GPI positive | 72.7% |
| IgM anti-β2GPI positive | 25% |
| IgA anti-β2GPI positive | 54.5% |
| IgG anti-CL positive | 77.2% |
| IgM anti-CL positive | 15.9% |
| IgA anti-CL positive | 59% |
| LA activity | 90% |
(PAPS: primary antiphospholipid syndrome; SAPS: secondary antiphospholipid syndrome; VT: vascular thrombosis; PM: pregnancy morbidities).